BofA/Merrill Lynch Downgrades Impax Laboratories (IPXL) to Underperform

March 18, 2010 8:36 AM EDT Send to a Friend
BofA/Merrill Lynch downgrades Impax Laboratories (Nasdaq: IPXL) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login